NCT00401024View on ClinicalTrials.gov

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 12, 2006

Primary Completion Date

February 4, 2008

Study Completion Date

November 11, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

imatinib mesylate

OTHER

pharmacological study

PROCEDURE

conventional surgery

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00401024 - Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma | Biotech Hunter | Biotech Hunter